Anticoagulation in COVID-19: a review of current literature and guidelines
B Narasimhan, M Lorente-Ros… - Hospital …, 2021 - Taylor & Francis
Severe acute respiratory syndrome coronavirus 2 infections are associated with greater risk
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …
Anticoagulation in COVID-19: a review of current literature and guidelines.
B Narasimhan, M Lorente-Ros… - Hospital Practice …, 2021 - europepmc.org
Severe acute respiratory syndrome coronavirus 2 infections are associated with greater risk
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …
Anticoagulation in COVID-19: a review of current literature and guidelines
B Narasimhan, M Lorente-Ros… - Hospital practice …, 2021 - pubmed.ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 infections are associated with greater risk
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …
Anticoagulation in COVID-19: a Review of Current Literature and Guidelines
B Narasimhan, M Lorente-Ros, JS Aguilar-Gallardo… - 2021 - touroscholar.touro.edu
Severe acute respiratory syndrome coronavirus 2 infections are associated with greater risk
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …